Neurology Alert – June 1, 2009
June 1, 2009
View Issues
-
Transcranial Magnetic Stimulation for the Treatment of Tinnitus
Repetitive transcranial magnetic stimulation appears to be a safe and effective method to treat chronic tinnitus. -
Myopathy with Pure Adolase Elevation
Isolated elevation of serum aldolase, with a clinical syndrome of myopathy, is a distinct disorder that predicts perimysial muscle pathology. -
Demyelinating Neuropathies as a Consequence of TNF-a-Blocker Therapy
Five cases of demyelinating neuropathy are reported as a consequence of treatment with anti-tumor necrosis factor drugs for auto-immune disorders. -
Radiosurgery for Mesial Temporal Lobe Epilepsy – A Possible Alternative to Temporal Lobectomy
This pilot study reports on the long-term efficacy, safety, and adverse events of focused radiosurgery as an alternative to temporal lobectomy for mesial temporal lobe epilepsy. -
A Modern View of Parkinson's Disease: Much More than Nigrostriatal Dopamine Deficiency
Many of the disabling symptoms of Parkinson's disease are unrelated to nigrostriatal dopamine deficiency, and unresponsive to dopamine replacement therapy. -
Botulinum Toxin Type B in Parkinson's Disease- related Drooling
Botulinum toxin type B injection into the parotid glands is safe and effective for PD-related drooling, with duration of action of 3–6 months. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.